RWJ-67657 (Standard) is the analytical standard of RWJ-67657. This product is intended for research and analytical applications. RWJ-67657 (JNJ 3026582) is an orally active and selective p38alpha and p38beta MAPK inhibitor with IC50s of 1 and 11 µM, respectively. RWJ-67657 displays no activity at p38gamma and p38delta, and exhibits cardio protective effect. Anti-inflammatory and anti-tumor activity[1].
Molecular Weight:
425.50
CAS Number:
[215303-72-3]
Formula:
C27H24FN3O
Target:
p38 MAPK,Reference Standards
Application Notes:
MCE Product type: Reference Standards
* VAT and and shipping costs not included. Errors and price changes excepted
